SightfileU.S. market data from official filings

PACIRA BIOSCIENCES INC COM (PCRX)

Name: PACIRA BIOSCIENCES INC COM (PCRX) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001396814 · EDGAR filings · Updated 2026-06-30

PACIRA BIOSCIENCES INC COM (PCRX) has reported institutional ownership of 110.2%, with 239 institutional managers holding positions valued at $980.3M per the latest 13F reporting period.

Institutional ownership

110.2%

Institutional managers

239

Reported 13F value

$980.3M

Insider activity

44 trans.

−$2.16M net selling

Latest updates

2026-06-30 — Current report (8-K) filed
2026-06-12 — Insider transaction reported (Form 4)
2026-06-12 — Insider transaction reported (Form 4)
2026-06-12 — Insider transaction reported (Form 4)
2026-06-12 — Insider transaction reported (Form 4)
2026-06-12 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, PACIRA BIOSCIENCES INC COM has 239 institutional holders and institutional ownership of 110.2%.

Insider activity

Insiders reported 44 transactions (0 buys, 13 sells) across 14 reporting insiders, with a net reported value of −$2.16M.

Related companies

SMITH & NEPHEW PLC (SNN) · STAAR SURGICAL CO (STAA) · TELADOC HEALTH INC (TDOC) · CADRE HLDGS INC (CDRE) · ARRIVENT BIOPHARMA INC (AVBP) · NOVAVAX INC (NVAX)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-30.